Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Khot

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Leukemia & Lymphoma|July 7, 2026
Durable response to salvage gilteritinib, allogeneic stem cell rescue and maintenance therapy in relapsed AML with a <i>FLT3</i> N676K variantSamuel Grigg, Amit Khot, Andrew H Wei
Methods in Molecular Biology (Clifton, N.J.)|March 18, 2025
Graft-Versus-Host Disease Mouse Models: A Clinical-Translational PerspectiveJessica Elliott, Rachel Koldej, Amit Khot, et al.
The Lancet. Haematology|April 6, 2026
Who will watch the watchmen: unique challenges of T-cell redirecting therapies in T-cell malignanciesJessica Elliott, David Ritchie, Rachel Koldej, et al.
JMIR Research Protocols|December 23, 2025
Establishing Barriers to and Enablers of Nurse-Enabled Subcutaneous Therapy Self-Administration Programs for Patients With Myeloma: Protocol for a Qualitative Descriptive StudyHayley Beer, Lisa Guccione, Amit Khot, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 14, 2023
Enablers and barriers to referral and delivery of multidisciplinary prehabilitation in the autologous stem cell transplant population: a theory-based interview studyJessica Crowe, Lara Edbrooke, Amit Khot, et al.
Cancers|August 14, 2025
Ribosome Biogenesis and Function in Cancer: From Mechanisms to TherapyKezia Gitareja, Shalini S Chelliah, Elaine Sanij, et al.
Ejhaem|May 14, 2025
Assessment of the Tolerability and Optimal Dosing of the Combination of Brentuximab Vedotin and Lenalidomide in Patients With Relapsed or Refractory T-cell Lymphoma: Results of a Single-centre Phase 1 Dose-escalation StudyCarrie van der Weyden, Mathias Bressel, Amit Khot, et al.
Leukemia & Lymphoma|October 25, 2022
Acute kidney injury in patients receiving high-dose etoposide phosphate as conditioning prior to hematopoietic stem cell transplantation in hematologic malignancies may be associated with elevated body mass indexTamasine Stewart, Mark Dowling, Brett Janson, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 18, 2020
The role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in assessment of complex invasive fungal disease and opportunistic co-infections in patients with acute leukemia prior to allogeneic hematopoietic cell transplantAnthony Longhitano, Ramin Alipour, Amit Khot, et al.
Leukemia & Lymphoma|August 10, 2017
Comprehensive genomic characterization dissects the complex biology of a case of synchronous Burkitt lymphoma and myeloid malignancy with shared hematopoietic ancestryGeorgina L Ryland, Kate Jones, Michelle McBean, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Leukemia & Lymphoma|July 7, 2026
Durable response to salvage gilteritinib, allogeneic stem cell rescue and maintenance therapy in relapsed AML with a <i>FLT3</i> N676K variantSamuel Grigg, Amit Khot, Andrew H Wei
Methods in Molecular Biology (Clifton, N.J.)|March 18, 2025
Graft-Versus-Host Disease Mouse Models: A Clinical-Translational PerspectiveJessica Elliott, Rachel Koldej, Amit Khot, et al.
The Lancet. Haematology|April 6, 2026
Who will watch the watchmen: unique challenges of T-cell redirecting therapies in T-cell malignanciesJessica Elliott, David Ritchie, Rachel Koldej, et al.
JMIR Research Protocols|December 23, 2025
Establishing Barriers to and Enablers of Nurse-Enabled Subcutaneous Therapy Self-Administration Programs for Patients With Myeloma: Protocol for a Qualitative Descriptive StudyHayley Beer, Lisa Guccione, Amit Khot, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 14, 2023
Enablers and barriers to referral and delivery of multidisciplinary prehabilitation in the autologous stem cell transplant population: a theory-based interview studyJessica Crowe, Lara Edbrooke, Amit Khot, et al.
Cancers|August 14, 2025
Ribosome Biogenesis and Function in Cancer: From Mechanisms to TherapyKezia Gitareja, Shalini S Chelliah, Elaine Sanij, et al.
Ejhaem|May 14, 2025
Assessment of the Tolerability and Optimal Dosing of the Combination of Brentuximab Vedotin and Lenalidomide in Patients With Relapsed or Refractory T-cell Lymphoma: Results of a Single-centre Phase 1 Dose-escalation StudyCarrie van der Weyden, Mathias Bressel, Amit Khot, et al.
Leukemia & Lymphoma|October 25, 2022
Acute kidney injury in patients receiving high-dose etoposide phosphate as conditioning prior to hematopoietic stem cell transplantation in hematologic malignancies may be associated with elevated body mass indexTamasine Stewart, Mark Dowling, Brett Janson, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 18, 2020
The role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in assessment of complex invasive fungal disease and opportunistic co-infections in patients with acute leukemia prior to allogeneic hematopoietic cell transplantAnthony Longhitano, Ramin Alipour, Amit Khot, et al.
Leukemia & Lymphoma|August 10, 2017
Comprehensive genomic characterization dissects the complex biology of a case of synchronous Burkitt lymphoma and myeloid malignancy with shared hematopoietic ancestryGeorgina L Ryland, Kate Jones, Michelle McBean, et al.
Pageof 7